This report aims to provide a comprehensive presentation of the global market for Cell Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CDMO. This report contains market size and forecasts of Cell Therapy CDMO in global, including the following market information:
Global Cell Therapy CDMO Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cell Therapy CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stem Cell Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy CDMO include Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Therapy CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy CDMO Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cell Therapy CDMO Market Segment Percentages, by Type, 2022 (%)
Stem Cell
Non-Stem Cell
Global Cell Therapy CDMO Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cell Therapy CDMO Market Segment Percentages, by Application, 2022 (%)
Commercial
Academic Research
Others
Global Cell Therapy CDMO Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cell Therapy CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell Therapy CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell Therapy CDMO, market overview.
Chapter 2: Global Cell Therapy CDMO market size in revenue.
Chapter 3: Detailed analysis of Cell Therapy CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell Therapy CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell Therapy CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy CDMO Overall Market Size
2.1 Global Cell Therapy CDMO Market Size: 2022 VS 2030
2.2 Global Cell Therapy CDMO Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Therapy CDMO Players in Global Market
3.2 Top Global Cell Therapy CDMO Companies Ranked by Revenue
3.3 Global Cell Therapy CDMO Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell Therapy CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy CDMO Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell Therapy CDMO Market Size Markets, 2022 & 2030
4.1.2 Stem Cell
4.1.3 Non-Stem Cell
4.2 By Type - Global Cell Therapy CDMO Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy CDMO Revenue, 2018-2023
4.2.2 By Type - Global Cell Therapy CDMO Revenue, 2024-2030
4.2.3 By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy CDMO Market Size, 2022 & 2030
5.1.2 Commercial
5.1.3 Academic Research
5.1.4 Others
5.2 By Application - Global Cell Therapy CDMO Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy CDMO Revenue, 2018-2023
5.2.2 By Application - Global Cell Therapy CDMO Revenue, 2024-2030
5.2.3 By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell Therapy CDMO Market Size, 2022 & 2030
6.2 By Region - Global Cell Therapy CDMO Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy CDMO Revenue, 2018-2023
6.2.2 By Region - Global Cell Therapy CDMO Revenue, 2024-2030
6.2.3 By Region - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell Therapy CDMO Revenue, 2018-2030
6.3.2 US Cell Therapy CDMO Market Size, 2018-2030
6.3.3 Canada Cell Therapy CDMO Market Size, 2018-2030
6.3.4 Mexico Cell Therapy CDMO Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell Therapy CDMO Revenue, 2018-2030
6.4.2 Germany Cell Therapy CDMO Market Size, 2018-2030
6.4.3 France Cell Therapy CDMO Market Size, 2018-2030
6.4.4 U.K. Cell Therapy CDMO Market Size, 2018-2030
6.4.5 Italy Cell Therapy CDMO Market Size, 2018-2030
6.4.6 Russia Cell Therapy CDMO Market Size, 2018-2030
6.4.7 Nordic Countries Cell Therapy CDMO Market Size, 2018-2030
6.4.8 Benelux Cell Therapy CDMO Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell Therapy CDMO Revenue, 2018-2030
6.5.2 China Cell Therapy CDMO Market Size, 2018-2030
6.5.3 Japan Cell Therapy CDMO Market Size, 2018-2030
6.5.4 South Korea Cell Therapy CDMO Market Size, 2018-2030
6.5.5 Southeast Asia Cell Therapy CDMO Market Size, 2018-2030
6.5.6 India Cell Therapy CDMO Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell Therapy CDMO Revenue, 2018-2030
6.6.2 Brazil Cell Therapy CDMO Market Size, 2018-2030
6.6.3 Argentina Cell Therapy CDMO Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy CDMO Revenue, 2018-2030
6.7.2 Turkey Cell Therapy CDMO Market Size, 2018-2030
6.7.3 Israel Cell Therapy CDMO Market Size, 2018-2030
6.7.4 Saudi Arabia Cell Therapy CDMO Market Size, 2018-2030
6.7.5 UAE Cell Therapy CDMO Market Size, 2018-2030
7 Cell Therapy CDMO Companies Profiles
7.1 Charles River
7.1.1 Charles River Company Summary
7.1.2 Charles River Business Overview
7.1.3 Charles River Cell Therapy CDMO Major Product Offerings
7.1.4 Charles River Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.1.5 Charles River Key News & Latest Developments
7.2 The Discovery Labs
7.2.1 The Discovery Labs Company Summary
7.2.2 The Discovery Labs Business Overview
7.2.3 The Discovery Labs Cell Therapy CDMO Major Product Offerings
7.2.4 The Discovery Labs Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.2.5 The Discovery Labs Key News & Latest Developments
7.3 BIOCENTRIQ
7.3.1 BIOCENTRIQ Company Summary
7.3.2 BIOCENTRIQ Business Overview
7.3.3 BIOCENTRIQ Cell Therapy CDMO Major Product Offerings
7.3.4 BIOCENTRIQ Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.3.5 BIOCENTRIQ Key News & Latest Developments
7.4 FUJIFILM Diosynth Biotechnologies
7.4.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Major Product Offerings
7.4.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.4.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.5 Exothera
7.5.1 Exothera Company Summary
7.5.2 Exothera Business Overview
7.5.3 Exothera Cell Therapy CDMO Major Product Offerings
7.5.4 Exothera Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.5.5 Exothera Key News & Latest Developments
7.6 WuXi AppTec
7.6.1 WuXi AppTec Company Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell Therapy CDMO Major Product Offerings
7.6.4 WuXi AppTec Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTec Key News & Latest Developments
7.7 Pharmaron
7.7.1 Pharmaron Company Summary
7.7.2 Pharmaron Business Overview
7.7.3 Pharmaron Cell Therapy CDMO Major Product Offerings
7.7.4 Pharmaron Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.7.5 Pharmaron Key News & Latest Developments
7.8 OBiO
7.8.1 OBiO Company Summary
7.8.2 OBiO Business Overview
7.8.3 OBiO Cell Therapy CDMO Major Product Offerings
7.8.4 OBiO Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.8.5 OBiO Key News & Latest Developments
7.9 Cell Therapies
7.9.1 Cell Therapies Company Summary
7.9.2 Cell Therapies Business Overview
7.9.3 Cell Therapies Cell Therapy CDMO Major Product Offerings
7.9.4 Cell Therapies Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.9.5 Cell Therapies Key News & Latest Developments
7.10 AGC Biologics
7.10.1 AGC Biologics Company Summary
7.10.2 AGC Biologics Business Overview
7.10.3 AGC Biologics Cell Therapy CDMO Major Product Offerings
7.10.4 AGC Biologics Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.10.5 AGC Biologics Key News & Latest Developments
7.11 Cytiva
7.11.1 Cytiva Company Summary
7.11.2 Cytiva Business Overview
7.11.3 Cytiva Cell Therapy CDMO Major Product Offerings
7.11.4 Cytiva Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.11.5 Cytiva Key News & Latest Developments
7.12 Helixmith
7.12.1 Helixmith Company Summary
7.12.2 Helixmith Business Overview
7.12.3 Helixmith Cell Therapy CDMO Major Product Offerings
7.12.4 Helixmith Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.12.5 Helixmith Key News & Latest Developments
7.13 ThermoGenesis
7.13.1 ThermoGenesis Company Summary
7.13.2 ThermoGenesis Business Overview
7.13.3 ThermoGenesis Cell Therapy CDMO Major Product Offerings
7.13.4 ThermoGenesis Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.13.5 ThermoGenesis Key News & Latest Developments
7.14 Anemocyte
7.14.1 Anemocyte Company Summary
7.14.2 Anemocyte Business Overview
7.14.3 Anemocyte Cell Therapy CDMO Major Product Offerings
7.14.4 Anemocyte Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.14.5 Anemocyte Key News & Latest Developments
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Company Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Cell Therapy CDMO Major Product Offerings
7.15.4 Thermo Fisher Scientific Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.15.5 Thermo Fisher Scientific Key News & Latest Developments
7.16 CBM
7.16.1 CBM Company Summary
7.16.2 CBM Business Overview
7.16.3 CBM Cell Therapy CDMO Major Product Offerings
7.16.4 CBM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.16.5 CBM Key News & Latest Developments
7.17 Bio Elpida
7.17.1 Bio Elpida Company Summary
7.17.2 Bio Elpida Business Overview
7.17.3 Bio Elpida Cell Therapy CDMO Major Product Offerings
7.17.4 Bio Elpida Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.17.5 Bio Elpida Key News & Latest Developments
7.18 Genezen
7.18.1 Genezen Company Summary
7.18.2 Genezen Business Overview
7.18.3 Genezen Cell Therapy CDMO Major Product Offerings
7.18.4 Genezen Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.18.5 Genezen Key News & Latest Developments
7.19 CCRM
7.19.1 CCRM Company Summary
7.19.2 CCRM Business Overview
7.19.3 CCRM Cell Therapy CDMO Major Product Offerings
7.19.4 CCRM Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.19.5 CCRM Key News & Latest Developments
7.20 RoslinCT
7.20.1 RoslinCT Company Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy CDMO Major Product Offerings
7.20.4 RoslinCT Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.20.5 RoslinCT Key News & Latest Developments
7.21 GenScript ProBio
7.21.1 GenScript ProBio Company Summary
7.21.2 GenScript ProBio Business Overview
7.21.3 GenScript ProBio Cell Therapy CDMO Major Product Offerings
7.21.4 GenScript ProBio Cell Therapy CDMO Revenue in Global Market (2018-2023)
7.21.5 GenScript ProBio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell Therapy CDMO Market Opportunities & Trends in Global Market
Table 2. Cell Therapy CDMO Market Drivers in Global Market
Table 3. Cell Therapy CDMO Market Restraints in Global Market
Table 4. Key Players of Cell Therapy CDMO in Global Market
Table 5. Top Cell Therapy CDMO Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell Therapy CDMO Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell Therapy CDMO Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell Therapy CDMO Product Type
Table 9. List of Global Tier 1 Cell Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy CDMO Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cell Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell Therapy CDMO Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cell Therapy CDMO Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell Therapy CDMO Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cell Therapy CDMO Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell Therapy CDMO Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cell Therapy CDMO Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell Therapy CDMO Revenue, (US$, Mn), 2024-2030
Table 30. Charles River Company Summary
Table 31. Charles River Cell Therapy CDMO Product Offerings
Table 32. Charles River Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 33. Charles River Key News & Latest Developments
Table 34. The Discovery Labs Company Summary
Table 35. The Discovery Labs Cell Therapy CDMO Product Offerings
Table 36. The Discovery Labs Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 37. The Discovery Labs Key News & Latest Developments
Table 38. BIOCENTRIQ Company Summary
Table 39. BIOCENTRIQ Cell Therapy CDMO Product Offerings
Table 40. BIOCENTRIQ Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 41. BIOCENTRIQ Key News & Latest Developments
Table 42. FUJIFILM Diosynth Biotechnologies Company Summary
Table 43. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offerings
Table 44. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 45. FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
Table 46. Exothera Company Summary
Table 47. Exothera Cell Therapy CDMO Product Offerings
Table 48. Exothera Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 49. Exothera Key News & Latest Developments
Table 50. WuXi AppTec Company Summary
Table 51. WuXi AppTec Cell Therapy CDMO Product Offerings
Table 52. WuXi AppTec Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 53. WuXi AppTec Key News & Latest Developments
Table 54. Pharmaron Company Summary
Table 55. Pharmaron Cell Therapy CDMO Product Offerings
Table 56. Pharmaron Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 57. Pharmaron Key News & Latest Developments
Table 58. OBiO Company Summary
Table 59. OBiO Cell Therapy CDMO Product Offerings
Table 60. OBiO Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 61. OBiO Key News & Latest Developments
Table 62. Cell Therapies Company Summary
Table 63. Cell Therapies Cell Therapy CDMO Product Offerings
Table 64. Cell Therapies Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 65. Cell Therapies Key News & Latest Developments
Table 66. AGC Biologics Company Summary
Table 67. AGC Biologics Cell Therapy CDMO Product Offerings
Table 68. AGC Biologics Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 69. AGC Biologics Key News & Latest Developments
Table 70. Cytiva Company Summary
Table 71. Cytiva Cell Therapy CDMO Product Offerings
Table 72. Cytiva Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 73. Cytiva Key News & Latest Developments
Table 74. Helixmith Company Summary
Table 75. Helixmith Cell Therapy CDMO Product Offerings
Table 76. Helixmith Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 77. Helixmith Key News & Latest Developments
Table 78. ThermoGenesis Company Summary
Table 79. ThermoGenesis Cell Therapy CDMO Product Offerings
Table 80. ThermoGenesis Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 81. ThermoGenesis Key News & Latest Developments
Table 82. Anemocyte Company Summary
Table 83. Anemocyte Cell Therapy CDMO Product Offerings
Table 84. Anemocyte Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 85. Anemocyte Key News & Latest Developments
Table 86. Thermo Fisher Scientific Company Summary
Table 87. Thermo Fisher Scientific Cell Therapy CDMO Product Offerings
Table 88. Thermo Fisher Scientific Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 89. Thermo Fisher Scientific Key News & Latest Developments
Table 90. CBM Company Summary
Table 91. CBM Cell Therapy CDMO Product Offerings
Table 92. CBM Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 93. CBM Key News & Latest Developments
Table 94. Bio Elpida Company Summary
Table 95. Bio Elpida Cell Therapy CDMO Product Offerings
Table 96. Bio Elpida Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 97. Bio Elpida Key News & Latest Developments
Table 98. Genezen Company Summary
Table 99. Genezen Cell Therapy CDMO Product Offerings
Table 100. Genezen Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 101. Genezen Key News & Latest Developments
Table 102. CCRM Company Summary
Table 103. CCRM Cell Therapy CDMO Product Offerings
Table 104. CCRM Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 105. CCRM Key News & Latest Developments
Table 106. RoslinCT Company Summary
Table 107. RoslinCT Cell Therapy CDMO Product Offerings
Table 108. RoslinCT Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 109. RoslinCT Key News & Latest Developments
Table 110. GenScript ProBio Company Summary
Table 111. GenScript ProBio Cell Therapy CDMO Product Offerings
Table 112. GenScript ProBio Cell Therapy CDMO Revenue (US$, Mn) & (2018-2023)
Table 113. GenScript ProBio Key News & Latest Developments
List of Figures
Figure 1. Cell Therapy CDMO Segment by Type in 2022
Figure 2. Cell Therapy CDMO Segment by Application in 2022
Figure 3. Global Cell Therapy CDMO Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell Therapy CDMO Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cell Therapy CDMO Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy CDMO Revenue in 2022
Figure 8. By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cell Therapy CDMO Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 16. US Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 20. Germany Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 21. France Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 28. China Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 32. India Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 34. Brazil Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cell Therapy CDMO Revenue Market Share, 2018-2030
Figure 37. Turkey Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cell Therapy CDMO Revenue, (US$, Mn), 2018-2030
Figure 41. Charles River Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. The Discovery Labs Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. BIOCENTRIQ Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Exothera Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. WuXi AppTec Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pharmaron Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. OBiO Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cell Therapies Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AGC Biologics Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cytiva Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Helixmith Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. ThermoGenesis Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Anemocyte Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Thermo Fisher Scientific Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. CBM Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Bio Elpida Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Genezen Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. CCRM Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. RoslinCT Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. GenScript ProBio Cell Therapy CDMO Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
